Published in Infect Immun on June 01, 2002
NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog (2009) 2.31
Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol (2014) 1.81
Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One (2010) 1.75
Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J Immunol (2012) 1.43
A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLoS One (2013) 1.31
Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. J Immunol (2010) 1.13
Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium? Front Microbiol (2011) 1.04
Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection. Immunology (2006) 1.01
IFN-beta improves BCG immunogenicity by acting on DC maturation. J Leukoc Biol (2008) 1.00
Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection. Front Cell Infect Microbiol (2013) 0.96
Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei. PLoS Pathog (2010) 0.94
TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9. J Immunol (2012) 0.87
Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection--the double-edged sword? Biomed Res Int (2013) 0.87
Insights into battles between Mycobacterium tuberculosis and macrophages. Protein Cell (2014) 0.82
Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population-based cohort study in Taiwan. BMC Infect Dis (2014) 0.81
Induction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36. PLoS One (2014) 0.80
Interferon alpha treatment of patients with impaired interferon gamma signaling. J Clin Immunol (2013) 0.79
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial. EBioMedicine (2016) 0.78
Modulation of transcriptional and inflammatory responses in murine macrophages by the Mycobacterium tuberculosis mammalian cell entry (Mce) 1 complex. PLoS One (2011) 0.77
Fighting mycobacteria through ISGylation. EMBO Rep (2012) 0.76
AIM2 inhibits autophagy and IFN-β production during M. bovis infection. Oncotarget (2016) 0.76
Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer. IDCases (2017) 0.75
A simple, rapid, and sensitive DNA assay procedure. Anal Biochem (1980) 23.88
Immunology of tuberculosis. Annu Rev Immunol (2001) 14.26
The nature of the principal type 1 interferon-producing cells in human blood. Science (1999) 10.90
Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet (1993) 5.52
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci U S A (2001) 5.21
Macrophages as a source of HIV during opportunistic infections. Science (1997) 3.92
Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1999) 3.45
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol (1984) 3.36
Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med (1999) 2.98
Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sci U S A (1994) 2.90
Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med (1997) 2.90
Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol (2000) 2.75
PML induces a novel caspase-independent death process. Nat Genet (1998) 2.66
The host immune response to tuberculosis. Am J Respir Crit Care Med (1998) 2.35
Immune responses to intracellular bacteria. Curr Opin Immunol (2001) 1.75
The pathogenesis of tuberculosis. Annu Rev Microbiol (1996) 1.73
Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J Clin Invest (1995) 1.68
Cytokines and tuberculosis. J Leukoc Biol (1994) 1.45
Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood (1996) 1.41
CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. J Immunol (1994) 1.32
Cytokine regulation of the intracellular growth of Mycobacterium paratuberculosis in bovine monocytes. Infect Immun (1988) 1.29
Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis. Am J Respir Crit Care Med (1998) 1.22
Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha. J Clin Invest (1994) 1.19
Interferon decreases the growth inhibition of Mycobacterium avium-intracellulare complex by fresh human monocytes but not by culture-derived macrophages. J Infect Dis (1991) 1.06
Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha. Clin Exp Immunol (2001) 1.01
A role for T-helper type-1 and type-2 cytokines in the regulation of human monocyte apoptosis. Blood (1997) 1.00
IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression. J Immunol (1998) 0.99
Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis. Eur Cytokine Netw (2000) 0.98
Triggering of peritoneal macrophages with IFN-alpha/beta attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kappaB activation. J Immunol (1998) 0.96
Influence of interferon on human monocyte to macrophage development. Cell Immunol (1984) 0.95
Concurrent infection of human macrophages with HIV-1 and Mycobacterium avium results in decreased cell viability, increased M. avium multiplication and altered cytokine production. J Immunol (1993) 0.95
Culture at high density improves the ability of human macrophages to control mycobacterial growth. J Immunol (2001) 0.91
[Mycobacterium avium-intracellulare subcutaneous abscess after injections of interferon alpha in a patient treated for lymphoma]. Ann Dermatol Venereol (1996) 0.89
Effect of stimulation of human macrophages on intracellular survival of Mycobacterium bovis Bacillus Calmette-Guerin. Evaluation with a mycobacterial reporter strain. Am J Respir Crit Care Med (1999) 0.88
Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells. J Immunol (1999) 0.87
Interferon-alpha primes macrophages for lipopolysaccharide-induced apoptosis. Biochem Biophys Res Commun (1995) 0.85
Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein gp120. J Clin Invest (1994) 0.84
Interaction between Mycobacterium avium and human immunodeficiency virus type 1 (HIV-1) in bronchoalveolar macrophages of normal and HIV-1-infected subjects. Am J Respir Cell Mol Biol (1994) 0.84
Infection of HIV-1 transgenic mice with Mycobacterium avium induces the expression of infectious virus selectively from a Mac-1-positive host cell population. J Immunol (1999) 0.83
Acute and long-term changes in T-lymphocyte subsets in response to clinical and subclinical measles. A community study from rural Senegal. Scand J Infect Dis (1998) 0.81
Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia. Br J Haematol (1992) 0.78
Interaction with human immunodeficiency virus type 1 modulates innate effector functions of human monocytes. J Infect Dis (1995) 0.78
Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and alpha-interferon immunotherapy. Bone Marrow Transplant (1996) 0.77
Inhibitory effect of interferon-alpha on respiratory burst and glucose metabolism in phagocytic cells. J Interferon Res (1994) 0.77
[Coomb's-positive hemolytic anemia and tuberculosis in Kaposi's sarcoma treated with interferon]. Harefuah (1994) 0.77
Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science (2003) 6.20
HIV drug resistance. N Engl J Med (2004) 5.52
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature (2005) 3.53
Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss. PLoS Pathog (2009) 2.06
Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapine. J Acquir Immune Defic Syndr (2005) 1.80
Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. J Virol (2006) 1.68
Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol (2009) 1.60
Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment. J Virol (2007) 1.50
Three-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis. Am J Respir Crit Care Med (2002) 1.49
Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors. J Virol (2004) 1.37
T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis (2009) 1.27
Changes of the phagosomal elemental concentrations by Mycobacterium tuberculosis Mramp. Microbiology (2005) 1.17
Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients. J Virol (2006) 1.13
Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis. Antioxid Redox Signal (2012) 1.10
Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations. AIDS (2003) 1.08
Low genetic barrier to large increases in HIV-1 cross-resistance to protease inhibitors during salvage therapy. Antivir Ther (2006) 1.07
Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B. J Virol (2006) 1.01
Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death. J Biol Chem (2001) 0.99
Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity. J Virol (2011) 0.99
Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsid-cyclophilin A interactions on the infectivity of HIV-1. J Virol (2010) 0.95
Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type. Retrovirology (2009) 0.94
Disruption of the gene homologous to mammalian Nramp1 in Mycobacterium tuberculosis does not affect virulence in mice. Infect Immun (2002) 0.93
Induction of heme oxygenase-1, biliverdin reductase and H-ferritin in lung macrophage in smokers with primary spontaneous pneumothorax: role of HIF-1alpha. PLoS One (2010) 0.89
Papulonecrotic tuberculid on the scalp. Int J Dermatol (2008) 0.88
Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms. J Virol (2011) 0.87
Quantification of the effects on viral DNA synthesis of reverse transcriptase mutations conferring human immunodeficiency virus type 1 resistance to nucleoside analogues. J Virol (2005) 0.86
Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses. Retrovirology (2008) 0.86
Effect of formaldehyde on asthmatic response to inhaled allergen challenge. Environ Health Perspect (2006) 0.84
Effect of cell cycle arrest on the activity of nucleoside analogues against human immunodeficiency virus type 1. J Virol (2005) 0.84
Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles. J Virol (2013) 0.83
Detection of alveolar fibrocytes in idiopathic pulmonary fibrosis and systemic sclerosis. PLoS One (2013) 0.82
SNP typing reveals similarity in Mycobacterium tuberculosis genetic diversity between Portugal and Northeast Brazil. Infect Genet Evol (2013) 0.80
Cough reflex sensitivity is decreased in female obese patients with obstructive sleep apnea. Respir Physiol Neurobiol (2007) 0.79
[Protective role of Nrf2 in the lungs against oxidative airway diseases]. Med Sci (Paris) (2011) 0.78
Repeated nitrogen dioxide exposures and eosinophilic airway inflammation in asthmatics: a randomized crossover study. Environ Health Perspect (2014) 0.77
Identification of Mycobacterium bovis among mycobacterial isolates from human clinical specimens at a university hospital in Rio de Janeiro, Brazil. J Bras Pneumol (2011) 0.77
Delaying reverse transcription does not increase sensitivity of HIV-1 to human TRIM5α. PLoS One (2013) 0.76
HGF and lung carcinoma: Don't forget neutrophils. Am J Respir Cell Mol Biol (2006) 0.75
Cytokines in pulmonary emphysema: can results in mice be translated to humans? Am J Respir Crit Care Med (2008) 0.75
[Is sarcoidosic anal fistula a real entity?]. Gastroenterol Clin Biol (2004) 0.75
[Metabolic and respiratory acidosis]. Rev Prat (2008) 0.75